| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/28/2009 | US20090136453 Methods for treating pain |
| 05/28/2009 | US20090136410 Stabilization and ionic triggering of nitric oxide release |
| 05/27/2009 | EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP1606381B1 Coated enzyme granules |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100491316C Novel compounds, their preparation and use |
| 05/27/2009 | CN100490810C Flashmelt oral dosage formulation |
| 05/27/2009 | CN100490809C Tablet comprising cetirizine and pseudoephedrine |
| 05/26/2009 | US7538231 Tyrosine kinase inhibitors |
| 05/26/2009 | US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 05/26/2009 | US7538084 Cyclosporins |
| 05/26/2009 | US7537784 Modified release tablet of bupropion hydrochloride |
| 05/26/2009 | US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 05/26/2009 | CA2439671C Aquatic animal treatment method and composition containing pimenta extract |
| 05/22/2009 | WO2005020913A3 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090130744 Apparatus and method to measure platelet contractility |
| 05/21/2009 | US20090130287 Microcrystalline Cellulose Compositions |
| 05/21/2009 | US20090130084 Tagged IgA1 proteases |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP1052974B1 Pharmaceutical formulation containing epothilone |
| 05/20/2009 | CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434572A Prodrugs of GABA analogs, compositions and uses thereof |
| 05/20/2009 | CN100488560C Method for preparing mass micro-capsule |
| 05/20/2009 | CN100488516C Use of compound in preparing medicament for pancreatic cancer treatment |
| 05/20/2009 | CN100488505C Use of Darifenacin and its salts |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 05/14/2009 | US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
| 05/14/2009 | US20090124563 Oral extended-release composition |
| 05/14/2009 | US20090124009 Antisense modulation of ptp1b expression |
| 05/13/2009 | EP1648471A4 Methods for the treatment of male and female sexual dysfunction |
| 05/13/2009 | EP1581759B1 Methods for treating taxol-induced sensory neuropathy |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | CN100486642C 疫苗 Vaccine |
| 05/12/2009 | US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 05/12/2009 | US7531693 Lipids for transfection of nucleic acids |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531555 Central nervous system disorders; schizophrenia; anxiolytic agents; Alzheimer's disease; Huntington's disease |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound |
| 05/12/2009 | CA2475302C Controlled synthesis of ziprasidone and compositions thereof |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/07/2009 | US20090118343 Treatment of severe distal colitis |
| 05/07/2009 | US20090118236 such as 2-[(3,5-dimethyl-4-(4'-hydroxy-3'-iso-propylbenzyl) phenoxy)methyl]-4-(3-chlorophenyl)-2-oxo-2 lambda 5-[1,3,2]-dioxaphosphonane, used for preventing and/or treating metabolic disorders such as obesity, hypercholesterolemia and hyperlipidemia |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117150 Functional Mutations In Respiratory Syncytial Virus |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP1682544A4 Hydroxylamine substituted imidazo ring compounds |
| 05/06/2009 | EP1667682A4 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7527798 Composition and method for preventing or treating a virus infection |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 04/30/2009 | WO2004098515A3 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 04/30/2009 | WO2004071436A3 The use of gcc ligands |
| 04/30/2009 | US20090111977 Antisense compound for inducing immunological tolerance |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2052720A2 Use of at least one hydroxylamine compound for the treatment of eye disease |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | CN101418045A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418044A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418043A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN100482673C Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/28/2009 | US7524636 assaying for level of pre-B cell colony-enhancing factor (PBEF), blocking labor; drug screening |
| 04/28/2009 | US7524624 Using druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins; viral fusion inhibitors |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | CA2279530C A method for the detection and localization of ductal exocrine pancreas tumours |
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105299 c-MET MODULATORS AND METHODS OF USE |
| 04/23/2009 | US20090105295 Hydroxylamine substituted imidazoquinolines |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105193 Crosslinked compounds and methods of making and using thereof |
| 04/22/2009 | EP2050453A1 Pharmaceutical combinations of meloxicam, tramadol and paracetamol |
| 04/22/2009 | EP1691739A4 Altering the stiffness, size, and/or shape of tissues for breathing disorders and other conditions |
| 04/22/2009 | EP1684696A4 Electrically activated alteration of body tissue stiffness for breathing disorders |
| 04/22/2009 | EP1587476A4 Novel compositions and methods in cancer |
| 04/22/2009 | EP1556694B1 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 04/22/2009 | CN101415451A Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 04/22/2009 | CN101415434A Methods and compositions for the treatment of B cell lymphomas and other cancers |
| 04/22/2009 | CN101415389A Dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |